<!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Archiving and Interchange DTD v1.0 20120330//EN" "JATS-archivearticle1.dtd">
<article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" article-type="correction"><?properties open_access?><front><journal-meta><journal-id journal-id-type="nlm-ta">Trials</journal-id><journal-id journal-id-type="iso-abbrev">Trials</journal-id><journal-title-group><journal-title>Trials</journal-title></journal-title-group><issn pub-type="epub">1745-6215</issn><publisher><publisher-name>BioMed Central</publisher-name><publisher-loc>London</publisher-loc></publisher></journal-meta><article-meta><article-id pub-id-type="pmid">27669981</article-id><article-id pub-id-type="pmc">5037580</article-id><article-id pub-id-type="publisher-id">1594</article-id><article-id pub-id-type="doi">10.1186/s13063-016-1594-8</article-id><article-categories><subj-group subj-group-type="heading"><subject>Erratum</subject></subj-group></article-categories><title-group><article-title>Erratum to: &#x02018;Effectiveness of biomarker-based exclusion of ventilator-acquired pneumonia to reduce antibiotic use (VAPrapid-2): study protocol for a randomised controlled trial&#x02019;</article-title></title-group><contrib-group><contrib contrib-type="author" corresp="yes"><name><surname>Hellyer</surname><given-names>Thomas P.</given-names></name><address><email>t.p.hellyer@ncl.ac.uk</email></address><xref ref-type="aff" rid="Aff1">1</xref></contrib><contrib contrib-type="author"><name><surname>Anderson</surname><given-names>Niall H.</given-names></name><xref ref-type="aff" rid="Aff2">2</xref></contrib><contrib contrib-type="author"><name><surname>Parker</surname><given-names>Jennie</given-names></name><xref ref-type="aff" rid="Aff3">3</xref></contrib><contrib contrib-type="author"><name><surname>Dark</surname><given-names>Paul</given-names></name><xref ref-type="aff" rid="Aff4">4</xref></contrib><contrib contrib-type="author"><name><surname>Van Den Broeck</surname><given-names>Tina</given-names></name><xref ref-type="aff" rid="Aff5">5</xref></contrib><contrib contrib-type="author"><name><surname>Singh</surname><given-names>Suveer</given-names></name><xref ref-type="aff" rid="Aff6">6</xref></contrib><contrib contrib-type="author"><name><surname>McMullan</surname><given-names>Ronan</given-names></name><xref ref-type="aff" rid="Aff7">7</xref></contrib><contrib contrib-type="author"><name><surname>Agus</surname><given-names>Ashley M.</given-names></name><xref ref-type="aff" rid="Aff8">8</xref></contrib><contrib contrib-type="author"><name><surname>Emerson</surname><given-names>Lydia M.</given-names></name><xref ref-type="aff" rid="Aff9">9</xref></contrib><contrib contrib-type="author"><name><surname>Blackwood</surname><given-names>Bronagh</given-names></name><xref ref-type="aff" rid="Aff9">9</xref></contrib><contrib contrib-type="author"><name><surname>Gossain</surname><given-names>Savita</given-names></name><xref ref-type="aff" rid="Aff10">10</xref></contrib><contrib contrib-type="author"><name><surname>Walsh</surname><given-names>Tim S.</given-names></name><xref ref-type="aff" rid="Aff11">11</xref></contrib><contrib contrib-type="author"><name><surname>Perkins</surname><given-names>Gavin D.</given-names></name><xref ref-type="aff" rid="Aff12">12</xref></contrib><contrib contrib-type="author"><name><surname>Morris</surname><given-names>Andrew Conway</given-names></name><xref ref-type="aff" rid="Aff13">13</xref></contrib><contrib contrib-type="author"><name><surname>McAuley</surname><given-names>Daniel F.</given-names></name><xref ref-type="aff" rid="Aff2">2</xref><xref ref-type="aff" rid="Aff8">8</xref><xref ref-type="aff" rid="Aff14">14</xref></contrib><contrib contrib-type="author"><name><surname>Simpson</surname><given-names>A. John</given-names></name><xref ref-type="aff" rid="Aff1">1</xref></contrib><aff id="Aff1"><label>1</label>Institute of Cellular Medicine, Newcastle University, Newcastle upon Tyne, UK </aff><aff id="Aff2"><label>2</label>Centre for Population Health Sciences, University of Edinburgh, Medical School, Edinburgh, UK </aff><aff id="Aff3"><label>3</label>Newcastle Clinical Trials Unit, Newcastle University, Newcastle upon Tyne, UK </aff><aff id="Aff4"><label>4</label>Institute of Inflammation and Repair, University of Manchester, Manchester Academic Health Sciences Centre &#x00026; Intensive Care Unit, Salford Royal NHS Foundation Trust, Greater Manchester, UK </aff><aff id="Aff5"><label>5</label>Becton Dickinson Biosciences, Erembodegem Aalst, Belgium </aff><aff id="Aff6"><label>6</label>Intensive Care Unit, Chelsea and Westminster Hospital, Imperial College London, London, UK </aff><aff id="Aff7"><label>7</label>Department of Medical Microbiology, Kelvin Building, The Royal Hospitals, Belfast, UK </aff><aff id="Aff8"><label>8</label>Northern Ireland Clinical Trials Unit, Elliot Dynes Building, The Royal Hospitals, Belfast, UK </aff><aff id="Aff9"><label>9</label>Centre for Experimental Medicine, Queen&#x02019;s University Belfast, Belfast, UK </aff><aff id="Aff10"><label>10</label>Public Health Laboratory, Heart of England NHS Foundation Trust, Birmingham, UK </aff><aff id="Aff11"><label>11</label>MRC Centre for Inflammation Research, University of Edinburgh, Edinburgh, UK </aff><aff id="Aff12"><label>12</label>University of Warwick and Heart of England NHS Foundation Trust, Coventry, UK </aff><aff id="Aff13"><label>13</label>Division of Anaesthesia, Department of Medicine, University of Cambridge, Addenbrooke&#x02019;s Hospital, Cambridge Biomedical Campus, Cambridge, UK </aff><aff id="Aff14"><label>14</label>Regional Intensive Care Unit, Royal Victoria Hospital, Belfast, UK </aff></contrib-group><pub-date pub-type="epub"><day>26</day><month>9</month><year>2016</year></pub-date><pub-date pub-type="pmc-release"><day>26</day><month>9</month><year>2016</year></pub-date><pub-date pub-type="collection"><year>2016</year></pub-date><volume>17</volume><elocation-id>465</elocation-id><history><date date-type="received"><day>30</day><month>8</month><year>2016</year></date><date date-type="accepted"><day>13</day><month>9</month><year>2016</year></date></history><permissions><copyright-statement>&#x000a9; The Author(s). 2016</copyright-statement><license license-type="OpenAccess"><license-p>
<bold>Open Access</bold>This article is distributed under the terms of the Creative Commons Attribution 4.0 International License (<ext-link ext-link-type="uri" xlink:href="http://creativecommons.org/licenses/by/4.0/">http://creativecommons.org/licenses/by/4.0/</ext-link>), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (<ext-link ext-link-type="uri" xlink:href="http://creativecommons.org/publicdomain/zero/1.0/">http://creativecommons.org/publicdomain/zero/1.0/</ext-link>) applies to the data made available in this article, unless otherwise stated.</license-p></license></permissions><related-article related-article-type="corrected-article" id="d30e69" ext-link-type="doi" xlink:href="10.1186/s13063-016-1442-x"/><custom-meta-group><custom-meta><meta-name>issue-copyright-statement</meta-name><meta-value>&#x000a9; The Author(s) 2016</meta-value></custom-meta></custom-meta-group></article-meta></front><body><sec id="Sec1"><title>Erratum</title><p>Unfortunately, the original version of this article [<xref ref-type="bibr" rid="CR1">1</xref>] contained an error. There are two references in the text to the threshold for defining VAP as greater than 10^4 colony forming units/ml. These should read greater OR EQUAL to 10^4 colony forming units/ml. The error is in the abstract and in the intervention sections.</p><p>In the abstract, please replace:</p><p>Patients with clinically suspected VAP undergo BAL and VAP is confirmed by growth of a potential pathogen at [&#x0003e;]10<sup>4</sup> colony forming units per millilitre (CFU/ml).</p><p>With the following correct version:</p><p>Patients with clinically suspected VAP undergo BAL and VAP is confirmed by growth of a potential pathogen at [&#x02265;]10<sup>4</sup> colony forming units per millilitre (CFU/ml).</p><p>In the Interventions, please replace:</p><p>VAP is confirmed by the widely used threshold of growth of a potential pathogen at [&#x0003e;]10<sup>4</sup> colony forming units per ml (CFU/ml)(13).</p><p>With the following correct version:</p><p>VAP is confirmed by the widely used threshold of growth of a potential pathogen at [&#x02265;]10<sup>4</sup> colony forming units per ml (CFU/ml)(13).</p></sec></body><back><fn-group><fn><p>The online version of the original article can be found under doi:10.1186/s13063-016-1442-x.</p></fn></fn-group><ref-list id="Bib1"><title>Reference</title><ref id="CR1"><label>1.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hellyer</surname><given-names>TP</given-names></name><name><surname>Anderson</surname><given-names>NH</given-names></name><name><surname>Jennie</surname><given-names>P</given-names></name><name><surname>Paul</surname><given-names>D</given-names></name><name><surname>Tina Van Den</surname><given-names>B</given-names></name><name><surname>Suveer</surname><given-names>S</given-names></name><name><surname>Ronan</surname><given-names>MM</given-names></name><name><surname>Agus</surname><given-names>AM</given-names></name><name><surname>Emerson</surname><given-names>LM</given-names></name><name><surname>Bronagh</surname><given-names>B</given-names></name><name><surname>Savita</surname><given-names>G</given-names></name><name><surname>Walsh</surname><given-names>TS</given-names></name><name><surname>Perkins</surname><given-names>GD</given-names></name><name><surname>Conway Morris</surname><given-names>A</given-names></name><name><surname>McAuley</surname><given-names>DF</given-names></name><name><surname>Simpson</surname><given-names>AJ</given-names></name></person-group><article-title>Effectiveness of biomarker-based exclusion of ventilator-acquired pneumonia to reduce antibiotic use (VAPrapid-2): study protocol for a randomised controlled trial</article-title><source>Trials</source><year>2016</year><volume>17</volume><fpage>318</fpage><pub-id pub-id-type="doi">10.1186/s13063-016-1442-x</pub-id><pub-id pub-id-type="pmid">27422026</pub-id></element-citation></ref></ref-list></back></article>